Smruthi Organics Reports Declining Sales and Profitability Challenges in June 2025 Results

Smruthi Organics, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results indicate a notable shift in the company's financial standing, with a revision in its score reflecting the challenges faced during this period.
The net sales for the quarter were recorded at Rs 18.99 crore, marking a significant decline compared to the average of Rs 31.50 crore over the previous four quarters. This downturn in sales is accompanied by a profit after tax (PAT) of Rs -1.10 crore, which also represents a considerable drop from the average PAT of Rs 0.89 crore in the prior quarters.

Additionally, the operating profit and operating profit margin have reached their lowest points in the last five quarters, with figures of Rs 0.23 crore and 1.21%, respectively. The earnings per share (EPS) also reflect a challenging environment, standing at Rs -0.96, indicating a reduction in profitability for shareholders.

Furthermore, the company's cash and cash equivalents have decreased to Rs 0.51 crore, highlighting a decline in short-term liquidity. The annual dividend per share has also been reduced to Rs 1.50, the lowest in five years, suggesting a shift in the company's distribution strategy.

Overall, these financial results have led to evaluation changes for Smruthi Organics, underscoring the difficulties encountered in the recent quarter.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.